These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30768726)

  • 41. Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity.
    Darko W; Medicis JJ; Smith A; Guharoy R; Lehmann DE
    Pharmacotherapy; 2003 May; 23(5):643-50. PubMed ID: 12741439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram.
    Yoon S; Park KR; Lee S; Song SH; Park WB; Jang IJ; Yu KS
    Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):233-238. PubMed ID: 28834212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of vancomycin and dosing recommendations for trauma patients.
    Medellín-Garibay SE; Ortiz-Martín B; Rueda-Naharro A; García B; Romano-Moreno S; Barcia E
    J Antimicrob Chemother; 2016 Feb; 71(2):471-9. PubMed ID: 26568565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimizing vancomycin dosage regimens in relation to high-flux haemodialysis.
    Hui K; Patel K; Nalder M; Nelson C; Buising K; Pedagogos E; Kong DCM; Kirkpatrick CMJ
    J Antimicrob Chemother; 2019 Jan; 74(1):130-134. PubMed ID: 30215721
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle.
    Allegaert K; Flint R; Smits A
    Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):735-749. PubMed ID: 31402708
    [No Abstract]   [Full Text] [Related]  

  • 46. SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients.
    Roberts JA; Choi GY; Joynt GM; Paul SK; Deans R; Peake S; Cole L; Stephens D; Bellomo R; Turnidge J; Wallis SC; Roberts MS; Roberts DM; Lassig-Smith M; Starr T; Lipman J
    BMC Infect Dis; 2016 Mar; 16():103. PubMed ID: 26932762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population Pharmacokinetics of Vancomycin in Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation.
    Okada A; Kariya M; Irie K; Okada Y; Hiramoto N; Hashimoto H; Kajioka R; Maruyama C; Kasai H; Hamori M; Nishimura A; Shibata N; Fukushima K; Sugioka N
    J Clin Pharmacol; 2018 Sep; 58(9):1140-1149. PubMed ID: 29762865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetic and Pharmacodynamic Characteristics of Vancomycin and Meropenem in Critically Ill Patients Receiving Sustained Low-efficiency Dialysis.
    Oliveira MS; Machado AS; Mendes ET; Chaves L; Perdigão Neto LV; Vieira da Silva C; Cavani Jorge Santos SR; Sanches C; Macedo E; Levin AS
    Clin Ther; 2020 Apr; 42(4):625-633. PubMed ID: 32199609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C.
    Kees MG; Hilpert JW; Gnewuch C; Kees F; Voegeler S
    Int J Antimicrob Agents; 2010 Dec; 36(6):545-8. PubMed ID: 20863668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implications of serum creatinine measurements on GFR estimation and vancomycin dosing in children.
    Neuman G; Nulman I; Adeli K; Koren G; Colantonio DA; Helldén A
    J Clin Pharmacol; 2014 Jul; 54(7):785-91. PubMed ID: 24596064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drug.
    Brown DL; Lalla CD; Masselink AJ
    Ther Drug Monit; 2013 Aug; 35(4):443-9. PubMed ID: 23851909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of and maintenance dose recommendations for vancomycin in severe pneumonia patients undergoing continuous venovenous hemofiltration with the combination of predilution and postdilution.
    Li Q; Liang F; Sang L; Li P; Lv B; Tan L; Liu X; Chen W
    Eur J Clin Pharmacol; 2020 Feb; 76(2):211-217. PubMed ID: 31734748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Benefit of Individualized Vancomycin Dosing Via Pharmacokinetic Tools: A Systematic Review and Meta-analysis.
    He N; Su S; Yan Y; Liu W; Zhai S
    Ann Pharmacother; 2020 Apr; 54(4):331-343. PubMed ID: 31694384
    [No Abstract]   [Full Text] [Related]  

  • 55. Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients.
    Colin PJ; Jonckheere S; Struys MMRF
    Clin Pharmacokinet; 2018 Nov; 57(11):1435-1447. PubMed ID: 29512049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis.
    Shimamoto Y; Fukuda T; Tanaka K; Komori K; Sadamitsu D
    Intensive Care Med; 2013 Jul; 39(7):1247-52. PubMed ID: 23604132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
    Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J
    J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DosOpt: A Tool for Personalized Bayesian Dose Adjustment of Vancomycin in Neonates.
    Tasa T; Metsvaht T; Kalamees R; Vilo J; Lutsar I
    Ther Drug Monit; 2017 Dec; 39(6):604-613. PubMed ID: 29084032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?
    Jamal JA; Mueller BA; Choi GY; Lipman J; Roberts JA
    Diagn Microbiol Infect Dis; 2015 May; 82(1):92-103. PubMed ID: 25698632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.